Japan’s Nippon Steel has completed its purchase of U.S. Steel after reaching a national-security agreement with the White ...

Regeneron Pharmaceuticals has declined to submit a new bid for genetic testing company 23andMe exceeding its original winning ...

June 13 (Reuters) - Anne Wojcicki is set to regain control of 23andMe after a $305 million bid from a nonprofit she controls ...

DNA testing firm 23andMe has been fined £2.31m by a UK watchdog over a data breach in 2023 which affected thousands of people ...

TTAM Research Institute, a non-profit public benefit company also founded by Wojcicki, won the auction with a $305 million ...

Anne Wojcicki’s winning bid to reclaim control of 23andMe doesn’t necessarily end the fight over what happens to the DNA of ...

Former 23andMe CEO Anne Wojcicki outbids Regeneron with a $305 million offer through her nonprofit TTAM to regain control of ...

A bankruptcy judge said he’ll rule as quickly as possible on 23andMe’s proposed sale of its assets, including the genetic ...

Anne Wojcicki, co-founder and former CEO of 23andMe, has bid to buy back the genetic testing platform, which was pronounced ...

The U.K. data protection watchdog has fined 23andMe £2.31 million ($3.1 million) for failing to protect U.K. residents’ ...

Regeneron did not bid higher on the genetic testing company because of “its assessment of 23andMe’s remaining value,” ...

Beleaguered genetic testing company 23andMe announced Friday that it has reached an agreement to sell itself to TTAM Research ...